These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 10867974

  • 1. Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine.
    Vanderschuren LJ, Schoffelmeer AN, Wardeh G, De Vries TJ.
    Psychopharmacology (Berl); 2000 May; 150(1):35-44. PubMed ID: 10867974
    [Abstract] [Full Text] [Related]

  • 2. Dose- and time-dependent bimodal effects of kappa-opioid agonists on locomotor activity in mice.
    Kuzmin A, Sandin J, Terenius L, Ogren SO.
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1031-42. PubMed ID: 11082438
    [Abstract] [Full Text] [Related]

  • 3. On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization.
    Vanderschuren LJ, Beemster P, Schoffelmeer AN.
    Psychopharmacology (Berl); 2003 Sep; 169(2):176-85. PubMed ID: 12768274
    [Abstract] [Full Text] [Related]

  • 4. Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist.
    Heidbreder CA, Schenk S, Partridge B, Shippenberg TS.
    Synapse; 1998 Nov; 30(3):255-62. PubMed ID: 9776129
    [Abstract] [Full Text] [Related]

  • 5. kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine.
    Shippenberg TS, LeFevour A, Heidbreder C.
    J Pharmacol Exp Ther; 1996 Feb; 276(2):545-54. PubMed ID: 8632320
    [Abstract] [Full Text] [Related]

  • 6. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.
    Acri JB, Thompson AC, Shippenberg T.
    Synapse; 2001 Mar 15; 39(4):343-50. PubMed ID: 11169785
    [Abstract] [Full Text] [Related]

  • 7. Kappa opioid agonists alter dopamine markers and cocaine-stimulated locomotor activity.
    Collins SL, Gerdes RM, D'Addario C, Izenwasser S.
    Behav Pharmacol; 2001 Jul 15; 12(4):237-45. PubMed ID: 11548109
    [Abstract] [Full Text] [Related]

  • 8. Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats.
    Morani AS, Kivell B, Prisinzano TE, Schenk S.
    Pharmacol Biochem Behav; 2009 Dec 15; 94(2):244-9. PubMed ID: 19747933
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of the kappa-opioid receptor agonist, U69593, on reinstatement of extinguished amphetamine self-administration behavior.
    Schenk S, Partridge B.
    Pharmacol Biochem Behav; 2001 Apr 15; 68(4):629-34. PubMed ID: 11526958
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Repeated treatment with the kappa opioid receptor agonist U69593 reverses enhanced K+ induced dopamine release in the nucleus accumbens, but not the expression of locomotor sensitization in amphetamine-sensitized rats.
    Escobar Adel P, Cornejo FA, Andrés ME, Fuentealba JA.
    Neurochem Int; 2012 Mar 15; 60(4):344-9. PubMed ID: 22306346
    [Abstract] [Full Text] [Related]

  • 14. Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats.
    Perreault ML, Graham D, Scattolon S, Wang Y, Szechtman H, Foster JA.
    Psychopharmacology (Berl); 2007 Nov 15; 194(4):485-96. PubMed ID: 17619861
    [Abstract] [Full Text] [Related]

  • 15. Multiplicity of kappa opioid receptor binding in the rat cardiac sarcolemma.
    Zhang WM, Jin WQ, Wong TM.
    J Mol Cell Cardiol; 1996 Jul 15; 28(7):1547-54. PubMed ID: 8841942
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice.
    Horan P, de Costa BR, Rice KC, Porreca F.
    J Pharmacol Exp Ther; 1991 Jun 15; 257(3):1154-61. PubMed ID: 1646325
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.